| Similar Articles |
|---|
 |
Pharmaceutical Executive
March 1, 2013 |
Who's Really in Charge of European Drug Registration? The European Commission blocks the authorization of a life-saving liver drug outside of France.   |
Pharmaceutical Executive
December 1, 2012
William Looney |
The Puzzle Master: Dr. Guido Rasi Europe's chief regulator charts a strategy from many moving parts. |
Pharmaceutical Executive
February 1, 2014 |
Will Europe's Regulatory Watchdog Come Of Age In 2014? The author looks at the growing pains of the European Medicine Agency as it faces key policy challenges of 2014. |
Pharmaceutical Executive
April 1, 2011 |
Dalli's Formula Fails the Efficacy Test EU leadership on pharma policy leaves many wondering of the right man is at the helm. |
Pharmaceutical Executive
October 1, 2011 |
The Essential--and Effective--Bureaucrat Fernand Sauer, First Director General, European Medicines Agency, has witnessed the progressive sterilization of innovative research due to a trend toward ever-larger industry concentration. |
Pharmaceutical Executive
June 1, 2012 |
Europe Responds to Medical Device 'Crisis' A recent medical device controversy in France has pushed European health ministers to agree on a crisis management program for the troubled sector. |
Pharmaceutical Executive
March 1, 2012 |
The Italian's Job After his predecessor and countryman left the EMA in disgrace, Guido Rasi jumps in as executive director with great challenges ahead. |
Pharmaceutical Executive
April 1, 2014 |
Whatever Happened To Faster Reimbursement For Generics In Europe? The plan to accelerate generic pricing and reimbursement has become another tragic European casualty. |
Pharmaceutical Executive
December 1, 2010 |
The Sum of All His Parts: Career Reflections of Europe's Chief Drug Regulator The European Medicines Agency is a unique institution, pursuing a mandate shared with a complex web of national and regional groups, each able to place a distinctive imprint around the delicate task of certifying the safety and efficacy of new drugs. |
Pharmaceutical Executive
November 1, 2014 |
EMA -- a Pioneer Permanently At Bay Agency's plan for reporting clinical trial data has sparked strong reactions from health campaigners, industry, and patients. |
Pharmaceutical Executive
June 1, 2011 |
A Lack of Information Why has the EU still not managed to update its rules on information about medicines? |
Chemistry World
September 30, 2014 |
Transparency measures forced on pharma Previous misdemeanors are compelling the pharmaceutical industry to be more open with financial information and clinical data. |
Pharmaceutical Executive
September 1, 2005
Sarah Houlton |
Global Report: Kids 'R' EU After years of delay, the European Parliament is ready to vote on pediatric-testing legislation. |
Pharmaceutical Executive
November 1, 2011 |
Europe Tackles 'Advertising in Disguise' Fears The EC's latest proposals have thrown water on Europe's fiery Direct-to-Consumer advertising debate. But is it enough to keep the flames at bay? |
Pharmaceutical Executive
June 1, 2014 |
Hopes High as EU Heads Into Leadership Change The principal drug industry associations in Europe launched a call in mid-May for "an integrated European industrial policy for the pharmaceuticals sector." |
Pharmaceutical Executive
November 1, 2013
Jill Wechsler |
Transparency Troubles for Pharma High prices, murky financial relations, and a reluctance to disclose clinical data undermine public trust in industry and the research enterprise. |
BusinessWeek
November 15, 2004
John Rossant |
And Europe Thinks The U.S. Is A Mess? The European Union is so polarized that further integration may well prove impossible. |
Chemistry World
October 8, 2014
Phillip Broadwith |
EMA finalizes trial transparency rules The European Medicines Agency has finalized its policy for sharing data from clinical trials. |
Chemistry World
June 26, 2012
Sarah Houlton |
Roche rapped for side-effect reporting failure Roche has been rapped by the European Medicines Agency for failing to report a large number of potential drug side-effects. The UK's Medicines and Healthcare products Regulatory Agency identified deficiencies in the company's medicine safety reporting system. |
Pharmaceutical Executive
January 1, 2012 |
Here's to a Happier New Year? A turbulent year is ahead for European pharma, while EFPIA's Director General begins to rethink its approach to new science. |
Chemistry World
February 2, 2015
Rebecca Trager |
EU regulator calls for generic drug suspensions The European Medicines Agency) has accused an Indian contract research organization of systematic fraud, and has recommended suspending sales of hundreds of generic drug formulations in Europe. |
Chemistry World
January 7, 2014
Angeli Mehta |
Flu drug stockpile may be worthless The case for spending hundreds of millions of pounds stockpiling antivirals for use in a flu pandemic is based on 'judgement rather than on evidence of their effectiveness', according to a parliamentary committee. |
Chemistry World
July 10, 2012 |
Interview: EMA head Guido Rasi His five-year appointment comes during a period of dramatic change for the pharma industry, which is struggling with patent expirations for many of its biggest selling drugs and a paucity of new drugs coming through the pipeline to take their place. |
Chemistry World
April 27, 2015
Ned Stafford |
European parliament refuses to back diversion of research cash Key European parliament committees have overwhelmingly rejected a proposal to divert euro 2.7 billion of research funding to help finance a new EU-wide economic stimulus package. |
Chemistry World
July 3, 2014
Andy Extance |
EMA wrangles restrain trial data progress Tempers are being tested as the pharmaceutical industry's journey towards transparency on clinical trial data enters a critical phase. |
Fast Company
Rose Pastore |
Google Strikes Back Against Europe's Antitrust Charges Google published a blog post on Thursday responding to the European Commission's claims that some of its practices are anti-competitive. |
